Trials / Sponsors / Sensei Biotherapeutics, Inc.
Sensei Biotherapeutics, Inc.
Industry · 4 registered clinical trials.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Active Not Recruiting | A Study of SNS-101 (Anti VISTA) Monotherapy and in Combination With Cemiplimab in Patients With Advanced Solid Solid Tumor, Adult, Advanced Solid Tumor, Head and Neck Cancer | Phase 1 / Phase 2 | 2023-05-31 |
| Withdrawn | SNS-301 Monotherapy in High Risk MDS and CMML Myelodysplastic Syndromes, Chronic Myelomonocytic Leukemia (CMML) | Phase 2 | 2020-04-01 |
| Terminated | Addition of SNS-301 to Checkpoint Inhibitor Treatment in Metastatic/Recurrent SCCHN Squamous Cell Carcinoma of the Head and Neck | Phase 1 / Phase 2 | 2019-11-11 |
| Completed | Phase 1 Trial of PAN-301-1 (SNS-301) in Cancer Patients Prostate Cancer | Phase 1 | 2016-12-01 |